Pallas Capital Advisors LLC Purchases New Position in REGENXBIO Inc. (NASDAQ:RGNX)
Pallas Capital Advisors LLC acquired a new position in REGENXBIO Inc. (NASDAQ:RGNX – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 10,415 shares of the biotechnology company’s stock, valued at approximately $74,000. Other large investors have also bought and sold shares […]
